How to Get Your Employer to Cover GLP-1 Medications
A strategic guide to building the case for employer-sponsored weight loss medication coverage.
As GLP-1 medications prove their effectiveness for weight loss and related health conditions, a growing number of employers are adding coverage to their benefits packages. If your employer does not currently cover semaglutide or tirzepatide, you can advocate for change. The key is presenting a compelling business case that speaks to both employee wellbeing and the company's bottom line.
The Business Case for Employer GLP-1 Coverage
Employer Cost of Obesity (Per Employee/Year)
- Excess medical claims: $2,505/year average for obese employees vs. normal-weight
- Absenteeism: 5-10 additional sick days per year ($1,200-2,600 in lost productivity)
- Presenteeism: 12-15% reduced on-the-job productivity ($3,000-5,000/year)
- Workers' comp: Obese workers file twice as many claims at 7x the cost
- Disability: Obesity increases short-term and long-term disability claims by 76%
- Total employer cost of obesity: $6,700-10,000+/employee/year
ROI Data to Present to HR
When approaching your HR team, lead with numbers:
- 3-year ROI: Studies show that employer-sponsored GLP-1 programs return $2-4 for every $1 invested through reduced medical claims and improved productivity
- Medical claims reduction: Employees who achieve 10%+ weight loss see 20-30% lower medical claims over 3 years
- Diabetes prevention: Each diabetes case prevented saves the employer approximately $9,600/year in excess costs
- Cardiovascular risk: The SELECT trial showed 20% reduction in cardiovascular events with semaglutide, translating to fewer expensive hospitalizations
- Retention: Employees value health benefits highly; adding innovative benefits improves retention and recruitment
Step-by-Step: How to Approach Your Employer
- Identify the right contact. For large companies: Director of Benefits, VP of HR, or Chief People Officer. For smaller companies: HR Manager or business owner. Benefits consultants and brokers are often the true decision-makers.
- Time it right. Approach during the benefits planning cycle (typically 3-6 months before plan renewal). Open enrollment discussions are when benefit changes are most seriously considered.
- Frame it as a business proposal, not a personal request. Lead with the ROI data, not your personal need. Present it as a benefit that could help many employees.
- Gather allies. If multiple employees express interest, it carries more weight. An employee petition or wellness committee recommendation is powerful.
- Propose a pilot program. Suggest a limited pilot (50-100 employees, 6-12 months) with measurable outcomes. This reduces risk for the employer while generating internal data.
- Offer alternatives to full pharmacy coverage. HRA contributions, telehealth partnerships, or wellness stipends may be easier to implement than full insurance coverage.
Coverage Models Employers Can Implement
1. Full Pharmacy Benefit Coverage
Adding GLP-1 medications to the pharmacy formulary. Most expensive option but most comprehensive. Typically includes prior authorization requirements. Works best for self-insured employers who control their formulary.
2. Telehealth Partnership
Partnering with a telehealth GLP-1 provider (like Trimi Health) as a standalone benefit. Lower cost than full pharmacy coverage. Includes medical oversight, medication, and support. Can be offered as an employee perk without changing the insurance plan.
3. Health Reimbursement Arrangement (HRA)
The employer contributes a set amount to an HRA that employees can use for GLP-1 treatment. Gives employees choice of provider while limiting employer cost. Can be targeted to employees with qualifying health conditions.
4. Wellness Stipend
A monthly wellness allowance that employees can apply toward GLP-1 treatment. Simplest to implement. No pharmacy benefit changes needed. Employees handle their own provider selection.
Email Template for HR
Sample Email to HR/Benefits Team
Subject: Proposal: GLP-1 Weight Loss Medication Benefit
Dear [HR/Benefits Contact],
I am writing to propose that [Company Name] consider adding GLP-1 weight loss medication coverage to our benefits package. With over 40% of American adults affected by obesity, this benefit would serve a significant portion of our workforce.
The business case is compelling: obesity costs employers an estimated $6,700-10,000 per affected employee annually in excess medical claims, absenteeism, and reduced productivity. Research shows that GLP-1 treatment returns $2-4 for every $1 invested over 3 years through reduced healthcare utilization.
I would welcome the opportunity to discuss coverage options, including lower-cost alternatives to full pharmacy coverage such as telehealth partnerships or wellness stipends. A pilot program could demonstrate ROI with minimal risk.
Would you be open to a brief conversation about this during the upcoming benefits planning cycle?
If Your Employer Says No
- Ask about timeline. Many employers are evaluating GLP-1 coverage for future plan years. Knowing the timeline helps you plan.
- Request HSA contribution increases. Higher employer HSA contributions can offset GLP-1 costs.
- Use existing benefits creatively. HSA/FSA accounts, wellness reimbursements, and EAP benefits may partially cover GLP-1 costs.
- Explore affordable alternatives. Compounded GLP-1 medications at $200-500/month are accessible without employer coverage.
- Try again next year. Benefits decisions are made annually. Present updated data and employee interest each cycle.
Key Takeaways
- Obesity costs employers $6,700-10,000+ per affected employee annually
- GLP-1 treatment ROI for employers is $2-4 returned for every $1 invested
- Present the business case, not just personal need, when approaching HR
- Propose a pilot program to minimize employer risk
- Multiple coverage models exist beyond full pharmacy benefits
- If coverage is declined, use HSA/FSA and affordable compounded options
Disclaimer: This article is for informational purposes only. Employer benefits decisions involve legal, financial, and regulatory considerations beyond the scope of this article. Consult with benefits professionals for specific guidance.
Employer Partnership Programs
Trimi Health offers employer partnership programs for companies looking to provide GLP-1 benefits to their workforce.
Learn MoreMore on cost & affordability
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program.
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).